<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<meta property="og:title" content="5.3 Underrepresentation in clinical trials | Leadership for Cancer Informatics Research" />
<meta property="og:type" content="book" />


<meta property="og:description" content="Description about Course/Book." />



<meta name="date" content="2021-08-26" />


<meta name="description" content="Description about Course/Book.">

<title>5.3 Underrepresentation in clinical trials | Leadership for Cancer Informatics Research</title>

<script src="libs/header-attrs-2.9.5/header-attrs.js"></script>
<link href="libs/tufte-css-2015.12.29/tufte-fonts.css" rel="stylesheet" />
<link href="libs/tufte-css-2015.12.29/tufte-background.css" rel="stylesheet" />
<link href="libs/tufte-css-2015.12.29/tufte-italics.css" rel="stylesheet" />
<link href="libs/tufte-css-2015.12.29/tufte.css" rel="stylesheet" />


<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
</style>


<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="assets/style_ITN.css" type="text/css" />

</head>

<body>



<div class="row">
<div class="col-sm-12">
<div id="TOC">
<ul>
<li><a href="index.html#about-this-course">About this course</a></li>
<li><a href="1-introduction.html#introduction"><span class="toc-section-number">1</span> Introduction</a>
<ul>
<li><a href="1-1-motivation.html#motivation"><span class="toc-section-number">1.1</span> Motivation</a></li>
<li><a href="1-2-informatics-teams-challenges.html#informatics-teams-challenges"><span class="toc-section-number">1.2</span> Informatics teams challenges</a></li>
<li><a href="1-3-meet-the-team.html#meet-the-team"><span class="toc-section-number">1.3</span> Meet the team!</a></li>
</ul></li>
<li><a href="2-guidelines-for-multidisciplinary-informatics-teams.html#guidelines-for-multidisciplinary-informatics-teams"><span class="toc-section-number">2</span> Guidelines for multidisciplinary informatics teams</a>
<ul>
<li><a href="2-1-finding-and-creating-informatics-teams.html#finding-and-creating-informatics-teams"><span class="toc-section-number">2.1</span> Finding and creating informatics teams</a>
<ul>
<li><a href="2-1-finding-and-creating-informatics-teams.html#start-early"><span class="toc-section-number">2.1.1</span> <strong>Start early</strong></a></li>
<li><a href="2-1-finding-and-creating-informatics-teams.html#who-to-look-for"><span class="toc-section-number">2.1.2</span> <strong>Who to look for</strong></a></li>
<li><a href="2-1-finding-and-creating-informatics-teams.html#adjust-your-expectations"><span class="toc-section-number">2.1.3</span> <strong>Adjust your expectations</strong></a></li>
</ul></li>
<li><a href="2-2-communication-for-informatics-teams.html#communication-for-informatics-teams"><span class="toc-section-number">2.2</span> Communication for informatics teams</a>
<ul>
<li><a href="2-2-communication-for-informatics-teams.html#talk-first"><span class="toc-section-number">2.2.1</span> <strong>Talk first</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#take-your-time"><span class="toc-section-number">2.2.2</span> <strong>Take your time</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#come-up-with-questionshypotheses-together"><span class="toc-section-number">2.2.3</span> <strong>Come up with questions/hypotheses together</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#be-specific"><span class="toc-section-number">2.2.4</span> <strong>Be specific</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#be-compassionate"><span class="toc-section-number">2.2.5</span> <strong>Be compassionate</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#keep-contact"><span class="toc-section-number">2.2.6</span> <strong>Keep contact</strong></a></li>
<li><a href="2-2-communication-for-informatics-teams.html#schedule-extra-time"><span class="toc-section-number">2.2.7</span> <strong>Schedule extra time</strong></a></li>
</ul></li>
<li><a href="2-3-record-keeping-practices.html#record-keeping-practices"><span class="toc-section-number">2.3</span> Record keeping practices</a>
<ul>
<li><a href="2-3-record-keeping-practices.html#keep-organized-records-of-work"><span class="toc-section-number">2.3.1</span> <strong>Keep organized records of work</strong></a></li>
<li><a href="2-3-record-keeping-practices.html#keep-organized-records-of-communication"><span class="toc-section-number">2.3.2</span> <strong>Keep organized records of communication</strong></a></li>
<li><a href="2-3-record-keeping-practices.html#use-reports"><span class="toc-section-number">2.3.3</span> <strong>Use reports</strong></a></li>
</ul></li>
<li><a href="2-4-leadership-best-practices.html#leadership-best-practices"><span class="toc-section-number">2.4</span> Leadership best practices</a>
<ul>
<li><a href="2-4-leadership-best-practices.html#recognize-that-different-disciplines-require-deep-expertise"><span class="toc-section-number">2.4.1</span> <strong>Recognize that different disciplines require deep expertise</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#avoid-employee-isolation"><span class="toc-section-number">2.4.2</span> <strong>Avoid employee isolation</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#encourage-relationships-with-others-in-their-domain"><span class="toc-section-number">2.4.3</span> <strong>Encourage relationships with others in their domain</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#encourage-growth-outside-their-domain"><span class="toc-section-number">2.4.4</span> <strong>Encourage growth outside their domain</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#value-their-perspective-about-science-in-general"><span class="toc-section-number">2.4.5</span> <strong>Value their perspective about science in general</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#discuss-expectations-and-hypotheses"><span class="toc-section-number">2.4.6</span> <strong>Discuss expectations and hypotheses</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#advocate-authorship-and-idea-generation-for-all"><span class="toc-section-number">2.4.7</span> <strong>Advocate authorship and idea generation for all</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#check-on-them"><span class="toc-section-number">2.4.8</span> <strong>Check on them!</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#get-external-review-of-work"><span class="toc-section-number">2.4.9</span> <strong>Get external review of work</strong></a></li>
<li><a href="2-4-leadership-best-practices.html#support-diverse-teammate-work-schedules"><span class="toc-section-number">2.4.10</span> <strong>Support diverse teammate work schedules</strong></a></li>
</ul></li>
<li><a href="2-5-conclusion.html#conclusion"><span class="toc-section-number">2.5</span> Conclusion</a></li>
</ul></li>
<li><a href="3-informatics-project-guidelines.html#informatics-project-guidelines"><span class="toc-section-number">3</span> Informatics project guidelines</a>
<ul>
<li><a href="3-1-identifying-good-informatics-questions.html#identifying-good-informatics-questions"><span class="toc-section-number">3.1</span> Identifying good informatics questions</a>
<ul>
<li><a href="3-1-identifying-good-informatics-questions.html#steps-for-forming-questions"><span class="toc-section-number">3.1.1</span> Steps for forming questions</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-1"><span class="toc-section-number">3.1.2</span> STEP 1</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-2"><span class="toc-section-number">3.1.3</span> STEP 2</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-3"><span class="toc-section-number">3.1.4</span> STEP 3</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-4"><span class="toc-section-number">3.1.5</span> STEP 4</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-5"><span class="toc-section-number">3.1.6</span> STEP 5</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-6"><span class="toc-section-number">3.1.7</span> STEP 6</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-7"><span class="toc-section-number">3.1.8</span> STEP 7</a></li>
<li><a href="3-1-identifying-good-informatics-questions.html#step-8"><span class="toc-section-number">3.1.9</span> STEP 8</a></li>
</ul></li>
<li><a href="3-2-informatics-project-pitfalls.html#informatics-project-pitfalls"><span class="toc-section-number">3.2</span> Informatics project pitfalls</a></li>
<li><a href="3-3-informatics-project-pitfall-mitigation-methods.html#informatics-project-pitfall-mitigation-methods"><span class="toc-section-number">3.3</span> Informatics project pitfall mitigation methods</a></li>
<li><a href="3-4-conclusion-1.html#conclusion-1"><span class="toc-section-number">3.4</span> Conclusion</a></li>
</ul></li>
<li><a href="4-informatics-relationships.html#informatics-relationships"><span class="toc-section-number">4</span> Informatics relationships</a>
<ul>
<li><a href="4-1-cultivating-good-multidisciplinary-lab-relationships.html#cultivating-good-multidisciplinary-lab-relationships"><span class="toc-section-number">4.1</span> Cultivating good multidisciplinary lab relationships</a></li>
<li><a href="4-2-collaborating-with-informatics-experts.html#collaborating-with-informatics-experts"><span class="toc-section-number">4.2</span> Collaborating with informatics experts</a>
<ul>
<li><a href="4-2-collaborating-with-informatics-experts.html#the-benefits-of-collaboration"><span class="toc-section-number">4.2.1</span> The benefits of collaboration</a></li>
<li><a href="4-2-collaborating-with-informatics-experts.html#potential-challenges"><span class="toc-section-number">4.2.2</span> Potential challenges</a></li>
</ul></li>
<li><a href="4-3-employing-informatics-experts.html#employing-informatics-experts"><span class="toc-section-number">4.3</span> Employing informatics experts</a></li>
<li><a href="4-4-mentoring-informatics-students.html#mentoring-informatics-students"><span class="toc-section-number">4.4</span> Mentoring informatics students</a>
<ul>
<li><a href="4-4-mentoring-informatics-students.html#co-mentoringcollaborativeteam-mentoring"><span class="toc-section-number">4.4.1</span> Co-mentoring/collaborative/team mentoring</a></li>
<li><a href="4-4-mentoring-informatics-students.html#peer-mentoring"><span class="toc-section-number">4.4.2</span> Peer mentoring</a></li>
<li><a href="4-4-mentoring-informatics-students.html#electronic-mentoring"><span class="toc-section-number">4.4.3</span> Electronic mentoring</a></li>
<li><a href="4-4-mentoring-informatics-students.html#career-goals"><span class="toc-section-number">4.4.4</span> Career goals</a></li>
</ul></li>
<li><a href="4-5-conclusion-2.html#conclusion-2"><span class="toc-section-number">4.5</span> Conclusion</a></li>
</ul></li>
<li><a href="5-promoting-diversity.html#promoting-diversity"><span class="toc-section-number">5</span> Promoting diversity</a>
<ul>
<li><a href="5-1-diversity-is-beneficial.html#diversity-is-beneficial"><span class="toc-section-number">5.1</span> Diversity is beneficial</a></li>
<li><a href="5-2-underrepresentation-in-cancer-informatics.html#underrepresentation-in-cancer-informatics"><span class="toc-section-number">5.2</span> Underrepresentation in cancer informatics</a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#underrepresentation-in-clinical-trials"><span class="toc-section-number">5.3</span> Underrepresentation in clinical trials</a>
<ul>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#historical-injustice"><span class="toc-section-number">5.3.1</span> <strong>Historical injustice</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#health-care-inequity"><span class="toc-section-number">5.3.2</span> <strong>Health care inequity</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#poor-recruitment-and-inclusion"><span class="toc-section-number">5.3.3</span> <strong>Poor recruitment and inclusion</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#inadequate-researcher-cultural-competency-and-diversity"><span class="toc-section-number">5.3.4</span> <strong>Inadequate researcher cultural competency and diversity</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#barriers-of-access"><span class="toc-section-number">5.3.5</span> <strong>Barriers of access</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#lack-of-community-engagement-funding"><span class="toc-section-number">5.3.6</span> <strong>Lack of community engagement funding</strong></a></li>
<li><a href="5-3-underrepresentation-in-clinical-trials.html#other-aspects-of-funding"><span class="toc-section-number">5.3.7</span> <strong>Other aspects of funding</strong></a></li>
</ul></li>
<li><a href="5-4-strategies-to-promote-more-equitable-inclusion-in-clinical-trials.html#strategies-to-promote-more-equitable-inclusion-in-clinical-trials"><span class="toc-section-number">5.4</span> Strategies to promote more equitable inclusion in clinical trials</a></li>
<li><a href="5-5-what-does-it-take-for-clinical-research-to-be-ethical.html#what-does-it-take-for-clinical-research-to-be-ethical"><span class="toc-section-number">5.5</span> What does it take for clinical research to be ethical?</a></li>
<li><a href="5-6-research-practices-to-reduce-cancer-health-disparities.html#research-practices-to-reduce-cancer-health-disparities"><span class="toc-section-number">5.6</span> Research practices to reduce cancer health disparities</a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#ways-to-better-support-a-more-diverse-research-team"><span class="toc-section-number">5.7</span> Ways to better support a more diverse research team</a>
<ul>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#seek-additional-training-about-disparities-in-informatics-and-stem-careers"><span class="toc-section-number">5.7.1</span> Seek additional <strong>training about disparities</strong> in informatics and STEM careers</a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#acknowledge-mentees-differences"><span class="toc-section-number">5.7.2</span> <strong>Acknowledge mentee’s differences</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#work-to-create-a-safe-environment"><span class="toc-section-number">5.7.3</span> <strong>Work to create a safe environment</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#diverse-role-models"><span class="toc-section-number">5.7.4</span> <strong>Diverse role models</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#advocate-for-all-mentees"><span class="toc-section-number">5.7.5</span> <strong>Advocate for all mentees</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#support-a-healthy-relationship-with-failure"><span class="toc-section-number">5.7.6</span> Support a <strong>healthy relationship with failure</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#celebration-and-microaffirmations"><span class="toc-section-number">5.7.7</span> <strong>Celebration and microaffirmations</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#give-feedback-with-cultural-sensitivity"><span class="toc-section-number">5.7.8</span> <strong>Give feedback with cultural sensitivity</strong></a></li>
<li><a href="5-7-ways-to-better-support-a-more-diverse-research-team.html#consider-creating-a-document-of-mentor-and-mentee-expectations."><span class="toc-section-number">5.7.9</span> Consider creating a document of <strong>mentor and mentee expectations</strong>.</a></li>
</ul></li>
<li><a href="5-8-conclusion-3.html#conclusion-3"><span class="toc-section-number">5.8</span> Conclusion</a></li>
</ul></li>
<li><a href="6-informatics-lab-management-tools.html#informatics-lab-management-tools"><span class="toc-section-number">6</span> Informatics lab management tools</a>
<ul>
<li><a href="6-1-slack.html#slack"><span class="toc-section-number">6.1</span> Slack</a>
<ul>
<li><a href="6-1-slack.html#workspaces"><span class="toc-section-number">6.1.1</span> Workspaces</a></li>
<li><a href="6-1-slack.html#channels"><span class="toc-section-number">6.1.2</span> Channels</a></li>
<li><a href="6-1-slack.html#pins"><span class="toc-section-number">6.1.3</span> Pins</a></li>
<li><a href="6-1-slack.html#code"><span class="toc-section-number">6.1.4</span> Code</a></li>
<li><a href="6-1-slack.html#reminders"><span class="toc-section-number">6.1.5</span> Reminders</a></li>
<li><a href="6-1-slack.html#polls"><span class="toc-section-number">6.1.6</span> Polls</a></li>
</ul></li>
<li><a href="6-2-git-and-github.html#git-and-github"><span class="toc-section-number">6.2</span> Git and GitHub</a></li>
<li><a href="6-3-docker.html#docker"><span class="toc-section-number">6.3</span> Docker</a></li>
<li><a href="6-4-figshare.html#figshare"><span class="toc-section-number">6.4</span> Figshare</a></li>
<li><a href="6-5-rstudio-and-r-markdown.html#rstudio-and-r-markdown"><span class="toc-section-number">6.5</span> RStudio and R Markdown</a>
<ul>
<li><a href="6-5-rstudio-and-r-markdown.html#r-markdown-guidelines"><span class="toc-section-number">6.5.1</span> R Markdown guidelines</a></li>
</ul></li>
<li><a href="6-6-jupyter.html#jupyter"><span class="toc-section-number">6.6</span> Jupyter</a></li>
<li><a href="6-7-conclusion-4.html#conclusion-4"><span class="toc-section-number">6.7</span> Conclusion</a></li>
</ul></li>
<li><a href="about-the-authors.html#about-the-authors">About the authors</a></li>
<li><a href="references.html#references">References</a></li>
</ul>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12">
<div id="underrepresentation-in-clinical-trials" class="section level2" number="5.3">
<h2><span class="header-section-number">5.3</span> Underrepresentation in clinical trials</h2>
<p>Beyond underrepresentation of certain populations within research teams, there is also a lack of representation of various populations in clinical trials (in particular woman and people of specific racial and ethnic groups) <span class="citation">(<label for="tufte-mn-40" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-40" class="margin-toggle">Clark et al. 2019<span class="marginnote">Clark, Luther T., Laurence Watkins, Ileana L. Piña, Mary Elmer, Ola Akinboboye, Millicent Gorham, Brenda Jamerson, et al. 2019. <span>“Increasing <span>Diversity</span> in <span>Clinical</span> <span>Trials</span>: <span>Overcoming</span> <span>Critical</span> <span>Barriers</span>.”</span> <em>Current Problems in Cardiology</em> 44 (5): 148–72. <a href="https://doi.org/10.1016/j.cpcardiol.2018.11.002">https://doi.org/10.1016/j.cpcardiol.2018.11.002</a>.</span>)</span>. This is particularity true for cancer clinical trial studies <span class="citation">(<label for="tufte-mn-41" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-41" class="margin-toggle">Nazha et al. 2019<span class="marginnote">Nazha, Bassel, Manoj Mishra, Rebecca Pentz, and Taofeek K. Owonikoko. 2019. <span>“Enrollment of <span>Racial</span> <span>Minorities</span> in <span>Clinical</span> <span>Trials</span>: <span>Old</span> <span>Problem</span> <span>Assumes</span> <span>New</span> <span>Urgency</span> in the <span>Age</span> of <span>Immunotherapy</span>.”</span> <em>American Society of Clinical Oncology Educational Book</em>, May. <a href="https://doi.org/10.1200/EDBK_100021">https://doi.org/10.1200/EDBK_100021</a>.</span>)</span>. Furthermore there is also limited data collected about LGBTQ+ individuals <span class="citation">(<label for="tufte-mn-42" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-42" class="margin-toggle">Chen et al. 2019<span class="marginnote">Chen, Boyu, Hao Jin, Zhiwen Yang, Yingying Qu, Heng Weng, and Tianyong Hao. 2019. <span>“An Approach for Transgender Population Information Extraction and Summarization from Clinical Trial Text.”</span> <em>BMC Medical Informatics and Decision Making</em> 19 (Suppl 2). <a href="https://doi.org/10.1186/s12911-019-0768-1">https://doi.org/10.1186/s12911-019-0768-1</a>.</span>)</span>.</p>
<p>According to an FDA study in 2018, Black people represented 13.4% of the population, yet only 5% of clinical trial participants, while Hispanics and people of Latin American ancestry made up 18.1% of the population at the time, but less than 1% of clinical trial participants <span class="citation">(<label for="tufte-mn-43" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-43" class="margin-toggle">Coakley et al. 2012<span class="marginnote">Coakley, Meghan, Emmanuel Olutayo Fadiran, L. Jo Parrish, Rachel A. Griffith, Eleanor Weiss, and Christine Carter. 2012. <span>“Dialogues on <span>Diversifying</span> <span>Clinical</span> <span>Trials</span>: <span>Successful</span> <span>Strategies</span> for <span>Engaging</span> <span>Women</span> and <span>Minorities</span> in <span>Clinical</span> <span>Trials</span>.”</span> <em>Journal of Women’s Health</em> 21 (7): 713–16. <a href="https://doi.org/10.1089/jwh.2012.3733">https://doi.org/10.1089/jwh.2012.3733</a>.</span>)</span>.</p>
<p>Furthermore, when looking at oncology trials, whites (80% of participants) and males (59.8% of participants) continue to be overrepresented, according to a study in 2019 <span class="citation">(<label for="tufte-mn-44" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-44" class="margin-toggle">Nazha et al. 2019<span class="marginnote">Nazha, Bassel, Manoj Mishra, Rebecca Pentz, and Taofeek K. Owonikoko. 2019. <span>“Enrollment of <span>Racial</span> <span>Minorities</span> in <span>Clinical</span> <span>Trials</span>: <span>Old</span> <span>Problem</span> <span>Assumes</span> <span>New</span> <span>Urgency</span> in the <span>Age</span> of <span>Immunotherapy</span>.”</span> <em>American Society of Clinical Oncology Educational Book</em>, May. <a href="https://doi.org/10.1200/EDBK_100021">https://doi.org/10.1200/EDBK_100021</a>.</span>)</span>.</p>
<p>This lack of diversity in clinical trials is a problem because this results in less understanding about how particular patients will fare with a given treatment/vaccine/diagnosis etc. This lack of knowledge can result in furthering inequities in medical care <span class="citation">(<label for="tufte-mn-45" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-45" class="margin-toggle">Clark et al. 2019<span class="marginnote">Clark, Luther T., Laurence Watkins, Ileana L. Piña, Mary Elmer, Ola Akinboboye, Millicent Gorham, Brenda Jamerson, et al. 2019. <span>“Increasing <span>Diversity</span> in <span>Clinical</span> <span>Trials</span>: <span>Overcoming</span> <span>Critical</span> <span>Barriers</span>.”</span> <em>Current Problems in Cardiology</em> 44 (5): 148–72. <a href="https://doi.org/10.1016/j.cpcardiol.2018.11.002">https://doi.org/10.1016/j.cpcardiol.2018.11.002</a>.</span>)</span>.</p>
<p>Research suggests the following reasons for the lack of diversity in clinical trials:</p>
<div id="historical-injustice" class="section level3" number="5.3.1">
<h3><span class="header-section-number">5.3.1</span> <strong>Historical injustice</strong></h3>
<p>According to studies, marginalized groups such as Native Americans, people of Hispanic or Latin American ancestry, and Black Americans understandably distrust researchers at higher rates than white individuals due to historical injustices and inadequate medical care. <span class="citation"><label for="tufte-mn-46" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-46" class="margin-toggle">Mastroianni, Faden, and Federman (1999)<span class="marginnote">Mastroianni, Anna C., Ruth Faden, and Daniel Federman. 1999. <em>Inclusion of <span>Latino</span> <span>Women</span> in <span>Clinical</span> and <span>Research</span> <span>Studies</span>: <span>Scientific</span> <span>Suggestions</span> for <span>Assuring</span> <span>Legal</span> and <span>Ethical</span> <span>Integrity</span></em>. National Academies Press (US). <a href="https://www.ncbi.nlm.nih.gov/books/NBK236579/">https://www.ncbi.nlm.nih.gov/books/NBK236579/</a>.</span></span></p>
<blockquote>
<p>African Americans’ suspicions and fears that many sectors of American society are not trustworthy were <strong>logical and accurate interpretations</strong> of their perceptions and <strong>experiences</strong>. <span class="citation">(<label for="tufte-mn-47" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-47" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span></p>
</blockquote>
<p>Examples of historical injustices include:</p>
<ul>
<li><p><a href="https://www.mcgill.ca/oss/article/history/40-years-human-experimentation-america-tuskegee-study">Tuskegee syphilis trial</a>: A study in Tuskegee, Alabama about the outcomes of untreated syphilis in Black males (1932-1972) in which the patients were told they were being treated but were in fact not being treated <span class="citation">(<label for="tufte-mn-48" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-48" class="margin-toggle">McVean 2019<span class="marginnote">McVean, Ada. 2019. <span>“40 <span>Years</span> of <span>Human</span> <span>Experimentation</span> in <span>America</span>: <span>The</span> <span>Tuskegee</span> <span>Study</span>.”</span> <em>Office for Science and Society</em>. <a href="https://www.mcgill.ca/oss/article/history/40-years-human-experimentation-america-tuskegee-study">https://www.mcgill.ca/oss/article/history/40-years-human-experimentation-america-tuskegee-study</a>.</span>)</span>.</p></li>
<li><p><a href="https://www.reliasmedia.com/articles/141906-revisiting-the-unfortunate-experiment-in-new-zealand">“The Unfortunate experiment”</a>: A study in New Zealand (1966-1987) in which women diagnosed with a precursor to
cervical cancer were also similarly studied but patients were not offered standard treatments, they were not informed of their diagnosis, and they were not told that they were a part of a trial, nor given the opportunity to decide if they wanted to be a part of the trial <span class="citation">(<label for="tufte-mn-49" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-49" class="margin-toggle">Evans 2018<span class="marginnote">Evans, Gary. 2018. <span>“Revisiting the <span>‘<span>Unfortunate</span> <span>Experiment</span>’</span> in <span>New</span> <span>Zealand</span>.”</span> <a href="https://www.reliasmedia.com/articles/141906-revisiting-the-unfortunate-experiment-in-new-zealand?v=preview">https://www.reliasmedia.com/articles/141906-revisiting-the-unfortunate-experiment-in-new-zealand?v=preview</a>.</span>)</span>.</p></li>
<li><p><a href="https://www.nature.com/articles/d41586-020-02494-z">Henrietta Lacks and HeLa Cells</a>: In 1951, a patient named Henrietta Lacks was treated for cervical cancer at Johns Hopkins. Her cancerous cells turned out to be uniquely capable of surviving and reproducing and have been used widely in research for decades for many discoveries. Her family did not receive money from the companies that profited from her cells, and for decades her family was often not asked for consent as doctors and scientists revealed her name and medical records publicly <span class="citation">(<a href="#ref-noauthor_henrietta_2020" role="doc-biblioref"><span>“Henrietta <span>Lacks</span>: Science Must Right a Historical Wrong”</span> 2020</a>)</span>.</p></li>
</ul>
<blockquote>
<p>“I want scientists to acknowledge that HeLa cells came from an African American woman who was flesh and blood, who had a family and who had a story,” her granddaughter Jeri Lacks-Whye told Nature <span class="citation">(<a href="#ref-noauthor_henrietta_2020" role="doc-biblioref"><span>“Henrietta <span>Lacks</span>: Science Must Right a Historical Wrong”</span> 2020</a>)</span>.</p>
</blockquote>
<ul>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828982/pdf/AJPH.2013.301520.pdf">Sexually Transmitted Disease (STD) experiments in prisons and Guatemala</a>: This (1946-1948) study of STDs started by infecting prisoners in a US prison in Indiana but later moved to Guatemala. Overall this study involved infecting many vulnerable populations with STDs, including children, prostitutes, mentally ill patients, prisoners, indigenous people of Guatemala, and soldiers.</li>
</ul>
<blockquote>
<p>“…health officials intentionally infected at least 1308 of these people with syphilis, gonorrhea, and chancroid and conducted serology tests on others.” <span class="citation">(<label for="tufte-mn-50" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-50" class="margin-toggle">Rodriguez and García 2013<span class="marginnote">Rodriguez, Michael A., and Robert García. 2013. <span>“First, <span>Do</span> <span>No</span> <span>Harm</span>: <span>The</span> <span>US</span> <span>Sexually</span> <span>Transmitted</span> <span>Disease</span> <span>Experiments</span> in <span>Guatemala</span>.”</span> <em>American Journal of Public Health</em> 103 (12): 2122–26. <a href="https://doi.org/10.2105/AJPH.2013.301520">https://doi.org/10.2105/AJPH.2013.301520</a>.</span>)</span></p>
</blockquote>
<ul>
<li><a href="https://www.tandfonline.com/doi/full/10.1080/10508422.2012.730788">Radioactive iodine thyroid studies of Alaskan natives</a>:
In the 1950s, a study was conducted to examine the thyroid gland in Alaskan natives, in which participants were given doses of radioactive iodine that exceeded current recommendations. Beyond the riskiness of the dose of radiation, this study was unethical due to inadequate translation of research methods and consent forms, thus participants were not able to be properly informed about the risks of the study and therefore not able to provide proper consent. Furthermore, this also led to the inadequate exclusion of participants for pregnancy, lactation, and other conditions <span class="citation">(<label for="tufte-mn-51" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-51" class="margin-toggle">Hodge 2012<span class="marginnote">Hodge, Felicia Schanche. 2012. <span>“No <span>Meaningful</span> <span>Apology</span> for <span>American</span> <span>Indian</span> <span>Unethical</span> <span>Research</span> <span>Abuses</span>.”</span> <em>Ethics &amp; Behavior</em> 22 (6): 431–44. <a href="https://doi.org/10.1080/10508422.2012.730788">https://doi.org/10.1080/10508422.2012.730788</a>.</span>)</span>.</li>
</ul>
<p>Importantly, this is only a small subset of examples. Many other individuals among a variety of populations such as those who were imprisoned <span class="citation">(<label for="tufte-mn-52" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-52" class="margin-toggle">Rodriguez and García 2013<span class="marginnote">Rodriguez, Michael A., and Robert García. 2013. <span>“First, <span>Do</span> <span>No</span> <span>Harm</span>: <span>The</span> <span>US</span> <span>Sexually</span> <span>Transmitted</span> <span>Disease</span> <span>Experiments</span> in <span>Guatemala</span>.”</span> <em>American Journal of Public Health</em> 103 (12): 2122–26. <a href="https://doi.org/10.2105/AJPH.2013.301520">https://doi.org/10.2105/AJPH.2013.301520</a>.</span>)</span>, economically disadvantaged, those with mental disabilities, children, the elderly, those with mental illness <span class="citation">(<label for="tufte-mn-53" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-53" class="margin-toggle">Millum 2012<span class="marginnote">Millum, Joseph. 2012. <span>“Introduction: <span>Case</span> <span>Studies</span> in the <span>Ethics</span> of <span>Mental</span> <span>Health</span> <span>Research</span>.”</span> <em>The Journal of Nervous and Mental Disease</em> 200 (3): 230. <a href="https://doi.org/10.1097/NMD.0b013e318247cb5b">https://doi.org/10.1097/NMD.0b013e318247cb5b</a>.</span>)</span>, and those among other groups have also been abused by unethical research practices <span class="citation"><label for="tufte-mn-54" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-54" class="margin-toggle">Park and Grayson (2008)<span class="marginnote">Park, Stephanie S., and Mitchell H. Grayson. 2008. <span>“Clinical Research: <span>Protection</span> of the <span>‘Vulnerable?’</span>.”</span> <em>Journal of Allergy and Clinical Immunology</em> 121 (5): 1103–7. <a href="https://doi.org/10.1016/j.jaci.2008.01.014">https://doi.org/10.1016/j.jaci.2008.01.014</a>.</span></span>. This pattern of abuse and neglect has in many cases directly impacted individuals and their families or communities and has unsurprisingly made many people wary of participating in clinical research <span class="citation">(<label for="tufte-mn-55" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-55" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span>.</p>
<blockquote>
<p>“We, as African Americans were always the pilot test… I know because people have experienced it within my line, my family, my bloodline in [city name]. Yeah.” He continued by saying, “So I just think that we’ve been used and misused a lot of times within the African American community and in the lower parts of the devastation where the devastation lies.” <span class="citation">(<label for="tufte-mn-56" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-56" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span></p>
</blockquote>
<blockquote>
<p>“I’m thinking about horror stories like the Tuskegee experiment and things like that. Like stuff that for me, were mentioned back in school and were mentioned by my family members…”<span class="citation">(<label for="tufte-mn-57" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-57" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span></p>
</blockquote>
</div>
<div id="health-care-inequity" class="section level3" number="5.3.2">
<h3><span class="header-section-number">5.3.2</span> <strong>Health care inequity</strong></h3>
<p>Beyond such examples of extremely unethical studies and practices, marginalized populations such as people of certain racial and ethnic ancestry have also historically received poorer access to health care and poorer quality health care, thus discouraging their engagement with the health care system. <span class="citation">(<label for="tufte-mn-58" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-58" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>; <label for="tufte-mn-59" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-59" class="margin-toggle">Mastroianni, Faden, and Federman 1999<span class="marginnote">Mastroianni, Anna C., Ruth Faden, and Daniel Federman. 1999. <em>Inclusion of <span>Latino</span> <span>Women</span> in <span>Clinical</span> and <span>Research</span> <span>Studies</span>: <span>Scientific</span> <span>Suggestions</span> for <span>Assuring</span> <span>Legal</span> and <span>Ethical</span> <span>Integrity</span></em>. National Academies Press (US). <a href="https://www.ncbi.nlm.nih.gov/books/NBK236579/">https://www.ncbi.nlm.nih.gov/books/NBK236579/</a>.</span>; <label for="tufte-mn-60" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-60" class="margin-toggle">FitzGerald and Hurst 2017<span class="marginnote">FitzGerald, Chloë, and Samia Hurst. 2017. <span>“Implicit Bias in Healthcare Professionals: A Systematic Review.”</span> <em>BMC Medical Ethics</em> 18 (1): 1–18. <a href="https://doi.org/10.1186/s12910-017-0179-8">https://doi.org/10.1186/s12910-017-0179-8</a>.</span>; <label for="tufte-mn-61" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-61" class="margin-toggle">Hodge 2012<span class="marginnote">Hodge, Felicia Schanche. 2012. <span>“No <span>Meaningful</span> <span>Apology</span> for <span>American</span> <span>Indian</span> <span>Unethical</span> <span>Research</span> <span>Abuses</span>.”</span> <em>Ethics &amp; Behavior</em> 22 (6): 431–44. <a href="https://doi.org/10.1080/10508422.2012.730788">https://doi.org/10.1080/10508422.2012.730788</a>.</span>)</span></p>
<p>Many racial and ethnic groups in the US were historically more likely to be uninsured compared to white people and although coverage rates have been better in more recent history, unequal rates remain to today.<span class="citation">(<label for="tufte-mn-62" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-62" class="margin-toggle">Damico 2021<span class="marginnote">Damico, Anthony. 2021. <span>“Health <span>Coverage</span> by <span>Race</span> and <span>Ethnicity</span>, 2010-2019.”</span> <em>KFF</em>. <a href="https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-coverage-by-race-and-ethnicity/">https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-coverage-by-race-and-ethnicity/</a>.</span>)</span></p>
<p><img src="resources/images/05-promoting_diversity_files/figure-html/1OU5qeRgN_fojGbcyu2qEdwlcKpDO6BveWtYW_u1Hqd4_ge9427bed03_0_32.png" title="Figure showing differences in health insurance coverage of different racial and ethnic groups, with lower rates of uninsured individuals for white people and people of Asian ancestry" alt="Figure showing differences in health insurance coverage of different racial and ethnic groups, with lower rates of uninsured individuals for white people and people of Asian ancestry" width="100%"  /></p>
<p>[<a href="https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-coverage-by-race-and-ethnicity/">source</a>]</p>
<p>Even with similar access to care (which can be reduced by sociodemographic factors), people of marginalized racial and ethnic groups still have a history of receiving inferior health care <span class="citation">(<label for="tufte-mn-63" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-63" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span>.</p>
<p>These two issues among others have led to health disparities, including for cancer:</p>
<blockquote>
<p>An analysis of 1 million patients with cancer in the United States showed that blacks or African Americans have a 28% higher <strong>cancer-specific mortality</strong> compared with whites. This survival gap is independent of sociodemographic factors, disease stage, and access to treatments. Indeed, disparities exist along the continuum of care, from screening, access to care, and referral to subspecialty centers, to enrollment in clinical trials that define new approaches to cancer treatment. <span class="citation">(<label for="tufte-mn-64" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-64" class="margin-toggle">Nazha et al. 2019<span class="marginnote">Nazha, Bassel, Manoj Mishra, Rebecca Pentz, and Taofeek K. Owonikoko. 2019. <span>“Enrollment of <span>Racial</span> <span>Minorities</span> in <span>Clinical</span> <span>Trials</span>: <span>Old</span> <span>Problem</span> <span>Assumes</span> <span>New</span> <span>Urgency</span> in the <span>Age</span> of <span>Immunotherapy</span>.”</span> <em>American Society of Clinical Oncology Educational Book</em>, May. <a href="https://doi.org/10.1200/EDBK_100021">https://doi.org/10.1200/EDBK_100021</a>.</span>)</span></p>
</blockquote>
</div>
<div id="poor-recruitment-and-inclusion" class="section level3" number="5.3.3">
<h3><span class="header-section-number">5.3.3</span> <strong>Poor recruitment and inclusion</strong></h3>
<p>Due to concern about the time and effort required to find a more diverse set of participants and also due to implicit bias, many populations are not recruited at the same rate. <strong>Implicit bias</strong> is an unconscious negative evaluation of a person based on characteristics that are irrelevant <span class="citation">(<label for="tufte-mn-65" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-65" class="margin-toggle">FitzGerald and Hurst 2017<span class="marginnote">FitzGerald, Chloë, and Samia Hurst. 2017. <span>“Implicit Bias in Healthcare Professionals: A Systematic Review.”</span> <em>BMC Medical Ethics</em> 18 (1): 1–18. <a href="https://doi.org/10.1186/s12910-017-0179-8">https://doi.org/10.1186/s12910-017-0179-8</a>.</span>)</span>.</p>
<blockquote>
<p>Based on the available evidence, physicians and nurses manifest implicit biases to a similar degree as the general population. The following characteristics are at issue: race/ethnicity, gender, socio-economic status (SES), age, mental illness, weight, having AIDS, brain injured patients perceived to have contributed to their injury, intravenous drug users, disability, and social circumstances <span class="citation">(<label for="tufte-mn-66" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-66" class="margin-toggle">FitzGerald and Hurst 2017<span class="marginnote">FitzGerald, Chloë, and Samia Hurst. 2017. <span>“Implicit Bias in Healthcare Professionals: A Systematic Review.”</span> <em>BMC Medical Ethics</em> 18 (1): 1–18. <a href="https://doi.org/10.1186/s12910-017-0179-8">https://doi.org/10.1186/s12910-017-0179-8</a>.</span>)</span>.</p>
</blockquote>
<p>Sadly, this can result in researchers not including certain populations in their trials.
Indeed healthcare professionals have been shown to withhold care, such as treatment based on their own bias about if a particular individual would adhere to the protocol. Thus marginalized groups often aren’t even recruited for clinical trials <span class="citation">(<label for="tufte-mn-67" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-67" class="margin-toggle">Yates et al. 2020<span class="marginnote">Yates, Isabelle, Jennifer Byrne, Susan Donahue, Linda McCarty, and Allison Mathews. 2020. <span>“Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research.”</span> <em>ACRP</em>. <a href="https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/">https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/</a>.</span>)</span>.</p>
<p>Studies of attempts to regulate oncology trial participation to be more inclusive, show that still 48% did not meet target recruitment goals for recruiting underrepresented populations <span class="citation">(<label for="tufte-mn-68" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-68" class="margin-toggle">Yates et al. 2020<span class="marginnote">Yates, Isabelle, Jennifer Byrne, Susan Donahue, Linda McCarty, and Allison Mathews. 2020. <span>“Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research.”</span> <em>ACRP</em>. <a href="https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/">https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/</a>.</span>)</span>.</p>
</div>
<div id="inadequate-researcher-cultural-competency-and-diversity" class="section level3" number="5.3.4">
<h3><span class="header-section-number">5.3.4</span> <strong>Inadequate researcher cultural competency and diversity</strong></h3>
<p>In a study of clinical trial participants of marginalized groups, participants stated that they were more likely to trust a researcher if they seemed scientifically knowledgeable but also had an understanding of the <strong>history</strong> and <strong>context</strong> of the study population, as well as experience working with that population <span class="citation">(<label for="tufte-mn-69" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-69" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span>.</p>
<blockquote>
<p>In addition, participants noted that the enthusiasm, commitment, or passion of the researcher to help the population of interest and to study the topic of interest influenced how trustworthy the researcher appeared to be. <span class="citation">(<label for="tufte-mn-70" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-70" class="margin-toggle">Griffith et al. 2020<span class="marginnote">Griffith, Derek M., Emily Cornish Jaeger, Erin M. Bergner, Sarah Stallings, and Consuelo H. Wilkins. 2020. <span>“Determinants of <span>Trustworthiness</span> to <span>Conduct</span> <span>Medical</span> <span>Research</span>: <span>Findings</span> from <span>Focus</span> <span>Groups</span> <span>Conducted</span> with <span>Racially</span> and <span>Ethnically</span> <span>Diverse</span> <span>Adults</span>.”</span> <em>Journal of General Internal Medicine</em> 35 (10): 2969–75. <a href="https://doi.org/10.1007/s11606-020-05868-1">https://doi.org/10.1007/s11606-020-05868-1</a>.</span>)</span></p>
</blockquote>
<p>Participants also state that the feel more trusting and more willing to participant in trials with a researcher of a similar background. Thus, improving the diversity of research teams and supporting underrepresented investigators may help to recruit more diverse participants for clinical trials <span class="citation">(<label for="tufte-mn-71" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-71" class="margin-toggle">Yates et al. 2020<span class="marginnote">Yates, Isabelle, Jennifer Byrne, Susan Donahue, Linda McCarty, and Allison Mathews. 2020. <span>“Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research.”</span> <em>ACRP</em>. <a href="https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/">https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/</a>.</span>)</span>.</p>
</div>
<div id="barriers-of-access" class="section level3" number="5.3.5">
<h3><span class="header-section-number">5.3.5</span> <strong>Barriers of access</strong></h3>
<p>In a 2019 study, access to oncology trials was found to only be available to about 27% of US cancer patients <span class="citation">(<label for="tufte-mn-72" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-72" class="margin-toggle">Nazha et al. 2019<span class="marginnote">Nazha, Bassel, Manoj Mishra, Rebecca Pentz, and Taofeek K. Owonikoko. 2019. <span>“Enrollment of <span>Racial</span> <span>Minorities</span> in <span>Clinical</span> <span>Trials</span>: <span>Old</span> <span>Problem</span> <span>Assumes</span> <span>New</span> <span>Urgency</span> in the <span>Age</span> of <span>Immunotherapy</span>.”</span> <em>American Society of Clinical Oncology Educational Book</em>, May. <a href="https://doi.org/10.1200/EDBK_100021">https://doi.org/10.1200/EDBK_100021</a>.</span>)</span>.</p>
<p>There are many barriers to this access:</p>
<ul>
<li><p>Language:
One major important barrier is translation of recruitment materials to other languages.</p></li>
<li><p>Scheduling:
Another barrier can be the time at which participants are needed to be in person for a clinical trial. Some individuals need more accommodation if for example they can’t come to appointments during work hours due to having a job with an inflexible work schedule or due to care taking responsibilities.</p></li>
<li><p>Transportation &amp; location:
If it is more time consuming to get to appointments due to a need for public transportation or because an individual lives in a different area of town this can inhibit participation and retention of participants.</p></li>
<li><p>Health Literacy:
For individuals who don’t have the time, education, or other means necessary to learn about the importance of specific health interventions or preventative practices for example, they may not be recruited for trials as well as individuals that are regularly concerned with their health and spend leisure time investigating information about their health.<span class="citation">(<label for="tufte-mn-73" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-73" class="margin-toggle">Yates et al. 2020<span class="marginnote">Yates, Isabelle, Jennifer Byrne, Susan Donahue, Linda McCarty, and Allison Mathews. 2020. <span>“Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research.”</span> <em>ACRP</em>. <a href="https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/">https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/</a>.</span>)</span></p></li>
</ul>
</div>
<div id="lack-of-community-engagement-funding" class="section level3" number="5.3.6">
<h3><span class="header-section-number">5.3.6</span> <strong>Lack of community engagement funding</strong></h3>
<p>There has been historically a lack of funding to support equitable engagement of community stakeholders. However, community engagement can build trust, reduce stigma, increase access, recruitment and retention of more diverse participants for clinical trials.</p>
<p>Recent projects in which participants are recruited through community engagement, such as <a href="https://projectbrotherhood.net/about-us/">Project Brotherhood</a> (a community based project, that provides Black men in Chicago with health education within their communities) have been shown to help increase health screen participation.</p>
</div>
<div id="other-aspects-of-funding" class="section level3" number="5.3.7">
<h3><span class="header-section-number">5.3.7</span> <strong>Other aspects of funding</strong></h3>
<p>Most clinical trials are funded by the pharmaceutical industry which often leads to pressure for a more homogeneous population to improve the opportunity to see effects in patients without confounding patient-specific factors. However, trials that are funded by the NIH include more diverse participants that are more representative of the true population of patients with cancer in the US <span class="citation">(<label for="tufte-mn-74" class="margin-toggle">&#8853;</label><input type="checkbox" id="tufte-mn-74" class="margin-toggle">Yates et al. 2020<span class="marginnote">Yates, Isabelle, Jennifer Byrne, Susan Donahue, Linda McCarty, and Allison Mathews. 2020. <span>“Representation in Clinical Trials: A Review on Reaching Underrepresented Populations in Research.”</span> <em>ACRP</em>. <a href="https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/">https://acrpnet.org/2020/08/10/representation-in-clinical-trials-a-review-on-reaching-underrepresented-populations-in-research/</a>.</span>)</span>.</p>
</div>
</div>
<p style="text-align: center;">
<a href="5-2-underrepresentation-in-cancer-informatics.html"><button class="btn btn-default">Previous</button></a>
<a href="5-4-strategies-to-promote-more-equitable-inclusion-in-clinical-trials.html"><button class="btn btn-default">Next</button></a>
</p>
</div>
</div>



</body>
</html>
